ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Regular Plan

Other Plans and Options
  • 0.43 %Nav, as on 24-11-2023

  • Previous Nav

  • Net Change on 24-11-2023

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 7.69 7.14 30.70 15.95 20.46 19.04
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care - TRI 8.14 6.65 26.97 14.37 16.54 14.46

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 30.70 15.95 20.46 2.00 3,270.55
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 29.80 16.29 19.47 1.88 5,539.19
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 27.54 16.32 19.01 2.10 1,982.47
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 23.25 15.00 20.81 2.05 1,783.19
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 28.60 13.55 18.11 2.39 764.66
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 26.65 15.06 19.17 2.35 666.91

Fund Holdings as on 31-October-2023

  • Sun Pharmaceutical Industries Ltd.

  • Cipla Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Lupin Ltd.

  • Aurobindo Pharma Ltd.

  • Alkem Laboratories Ltd.

  • FDC Ltd.

  • Krsnaa Diagnostics Ltd.

  • Aster DM Healthcare Ltd.

  • Fortis Healthcare Ltd.

  • Zydus Lifesciences Ltd.

  • Divi's Laboratories Ltd.

  • Vijaya Diagnostic Centre Pvt Ltd.

  • Biocon Ltd.

  • Glaxosmithkline Pharmaceuticals Ltd.

  • TREPS

  • IPCA Laboratories Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Piramal Pharma Ltd.

  • Dishman Carbogen Amcis Ltd.

  • Mankind Pharma Ltd

  • SBI Life Insurance Company Ltd.

  • Thyrocare Technologies Ltd.

  • Indoco Remedies Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Viatris Inc.

  • HDFC Life Insurance Company Ltd.

  • Laxmi Organic Industries Ltd.

  • Eris Lifesciences Ltd.

  • Ajanta Pharma Ltd.

  • Windlas Biotech Ltd.

  • Advanced Enzyme Technologies Ltd.

  • Yatharth Hospital & Trauma Care Services Pvt Ltd

  • Syngene International Ltd.

  • Orchid Pharma Ltd.

  • Natco Pharma Ltd.

  • Healthcare Global Enterprises Ltd.

  • Jupiter Life Line Hospitals Ltd

  • Blue Jet Healthcare Ltd.

  • 182 Days Treasury Bills

  • 182 Days Treasury Bills

  • Alembic Pharmaceuticals Ltd.

  • Metropolis Healthcare Ltd.

  • ICICI Lombard General Insurance Company Ltd.

  • Narayana Hrudayalaya Ltd.

  • 182 Days Treasury Bills

  • Cash Margin - Derivatives

  • Net Current Assets

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Insurance

  • Miscellaneous

  • Chemicals

View More

  • Cash

  • Equity

  • SOV

View More

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

Scheme Analysis

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 13-Jul-2018 and currently has an AUM of ₹3,270.55 crore. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ended up ₹0.11(0.43%)yesterday to ₹25.5.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad .

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100